×

Biocompatible hydrogel treatments for retinal detachment

  • US 9,623,144 B2
  • Filed: 05/27/2015
  • Issued: 04/18/2017
  • Est. Priority Date: 05/11/2012
  • Status: Active Grant
First Claim
Patent Images

1. An in vivo gelling pre-formulation for the treatment of retinal detachment, comprising:

  • (a) multi-ARM nucleophilic polyol monomers having more than two nucleophilic arms, wherein each nucleophilic arm comprises a polyethyleneglycol chain and terminates in a nucleophilic amino group;

    wherein the nucleophilic arms of the multi-ARM nucleophilic polyol monomers are selected from

View all claims
  • 6 Assignments
Timeline View
Assignment View
    ×
    ×